Wilson Sonsini advised ArrePath on the deal. ArrePath, an anti-infective drug discovery company addressing drug resistant infections, announced it has raised $20 million in seed financing...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here